Feverfew is an annual, self seeding, tiny daisy that has been shown in Clinical Trials from Guy's Hospital Migraine Clinic in London to be an excellent prophylactic for migraine (2-3 leaves a day- they taste awful- a tea with peppermint might help disguise the taste).
This study, again, was from left field
Quote:
Quote:
|
Daisies Lead Scientists Down Path to New Leukemia Drug
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
The Rochester team has been leading the investigation of this promising therapy on the deadly blood cancer for nearly five years. And to bring it from a laboratory concept to patient studies in that time is very fast progress in the drug development world, said Craig T. Jordan, Ph.D., senior author of the Blood article and director of Translational Research for Hematologic Malignancies at the James P. Wilmot Cancer Center, at the University of Rochester Medical Center.
Clinical trials are expected to begin in England by the end of 2007. Investigators expect to initially enroll about a dozen adult volunteers who’ve been diagnosed with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) or other types of blood or lymph cancers, Jordan said.
Under development is dimethylamino-parthenolide (DMAPT), a form of parthenolide (PTL) that is derived from a daisy-like plant known as feverfew or bachelor’s button. DMAPT is a water-soluble agent that scientists believe will selectively target leukemia at the stem-cell
|
Daisies Lead Scientists Down Path to New Leukemia Drug - URMC Press Room
|
BTW Caraway from Google images
